Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Forte Biosciences, Inc. (FBRX) Total Current Liabilities (2016 - 2020)

Forte Biosciences (FBRX) has disclosed Total Current Liabilities for 5 consecutive years, with $2.4 million as the latest value for Q3 2020.

  • On a quarterly basis, Total Current Liabilities fell 94.22% to $2.4 million in Q3 2020 year-over-year; TTM through Sep 2020 was $2.4 million, a 94.22% decrease, with the full-year FY2019 number at $1.9 million, down 88.44% from a year prior.
  • Total Current Liabilities was $2.4 million for Q3 2020 at Forte Biosciences, down from $3.4 million in the prior quarter.
  • In the past five years, Total Current Liabilities ranged from a high of $41.7 million in Q3 2019 to a low of $1.9 million in Q4 2019.
  • A 5-year average of $14.8 million and a median of $15.6 million in 2017 define the central range for Total Current Liabilities.
  • Peak YoY movement for Total Current Liabilities: skyrocketed 186.05% in 2019, then plummeted 94.22% in 2020.
  • Forte Biosciences' Total Current Liabilities stood at $14.4 million in 2016, then rose by 20.5% to $17.3 million in 2017, then dropped by 4.59% to $16.5 million in 2018, then crashed by 88.44% to $1.9 million in 2019, then grew by 26.1% to $2.4 million in 2020.
  • Per Business Quant, the three most recent readings for FBRX's Total Current Liabilities are $2.4 million (Q3 2020), $3.4 million (Q2 2020), and $12.6 million (Q1 2020).